Dimensional Fund Advisors LP

SEC CIK: 0000354204
Latest filing: Aug 11, 2026

SEC filings (opens in a new tab)

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overview All 13F holders of HRTX Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 5; Since Q1 2021

Holdings of HRTX by Dimensional Fund Advisors LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−318,705−100.0%	Sold out	Holders
Q1 2022	318,705	$1.82M	<0.1%	−18,176−5.4%	Reduced	Holders
Q4 2021	336,881	$3.08M	<0.1%	+19,682+6.2%	Added	Holders
Q3 2021	317,199	$3.39M	<0.1%	−311,146−49.5%	Reduced	Holders
Q2 2021	628,345	$9.75M	<0.1%	+15,161+2.5%	Added	Holders
Q1 2021	613,184	$9.94M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.